Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
By restoring the body’s ability to produce KLK1, therapies are emerging for pree...
Researchers have developed a new AI approach to select chemical compounds that c...
Intensified strategies are reshaping biologics manufacturing by boosting speed, ...
Scientists from the Cedars-Sinai Board of Governors Regenerative Medicine Instit...
This eBook explores how researchers can move beyond correlation and towards mech...
Building on promising preclinical findings, researchers in South Korea are devel...
Investors unpack what it takes to succeed in an increasingly crowded AI biology ...
Researchers developed regulatory T cells armed with chimeric allergen receptors—...
A new therapeutic target shields nerve cells from the damage of ALS. A novel dru...
Less than a month after its stock roller-coastered on safety signals associated ...
It’s not easy to transplant a whole human eye. The surgery is difficult. And the...
As the parent of two little girls, I often think about how their childhood is di...
Using techniques including spatial transcriptomics, researchers identified a dev...
At the 74th ASMS Conference, the obvious story was hardware. But after several d...
In this episode of GEN's Touching Base, editors talk about the multi-billion-dol...
Elixirgen's lead program is an ex vivo autologous therapy based on proprietary t...